January 31, 2023
Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row
Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row.
Read More ›
January 26, 2022
Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row
Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row.
Read More ›
February 6, 2021
Alnylam Named to Bloomberg's 2021 Gender-Equality Index
Alnylam has been selected to Bloomberg's Gender-Equality Index for 2021
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site